Clinical Trials on Cellulite in India

Total 5 results

Novartis

Completed

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome (REMITTER)

Muckle Wells Syndrome

United States, Spain, United Kingdom, France, Germany, India
GlaxoSmithKline

Completed

Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

Skin Infections, Bacterial

United States, South Africa, India, Argentina, Brazil
GlaxoSmithKline

Completed

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Skin Infections, Bacterial

Netherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
Targanta Therapeutics Corporation

Completed

A Study for Patients With Complicated Skin and Skin Structure Infections (SIMPLIFI)

Wounds and Injuries | Streptococcal Infections | Abscess | Cellulitis | Staphylococcal Skin Infections

United States, Australia, India, Italy, Romania, Ukraine
Novartis

Completed

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Familial Cold Autoinflammatory Syndrome | Cryopyrin-Associated Periodic Syndromes | Neonatal Onset Multisystem Inflammatory Disease | Muckle Wells Syndrome

United States, Germany, Italy, Spain, United Kingdom, Turkey, France, Belgium, India

3

Subscribe